Leveraging on-table MR soft tissue imaging, MRIdian allows oncologists to visualize, adapt and target using diagnostic-quality anatomical detail that’s simply unavailable with conventional IGRT technologies.
Combining the latest innovations in precision radiation delivery, groundbreaking MR image guidance, and on-table adaptive therapy, MRIdian represents a new paradigm in radiation oncology.
Michigan Community Hospital Begins Patient Treatments with ViewRay’s MRIdian Linac
ViewRay, Inc. announced today that Sparrow Health System in Lansing, Michigan has begun patient treatments with MRIdian® Linac, a cutting-edge radiation therapy system that combines the latest innovations in precision radiation delivery and ground-breaking MRI-guidance.
First MRIdian MRI-Guided Radiotherapy Treatments Begin in the United Kingdom
GenesisCare Oxford Brings the Benefits of Continuous Soft-Tissue Imaging and Adaptive Treatment Delivery to UK Cancer Patients.
ViewRay to Present at the 2019 Piper Jaffray 31st Annual Healthcare Conference
ViewRay, Inc. today announced that the Company will participate in the 2019 Piper Jaffray 31st Annual Healthcare Conference in New York, New York.
A new kind of medical technology company, ViewRay® Inc. designs, manufactures and markets MRIdian – the world’s first MRI-guided radiation therapy system to image and treat cancer patients simultaneously.
Contact Us Today To Learn More Contact
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy